Helicoter 200 mg Capsule

Helicoter Capsule contains Pylopass™ (Lactobacillus reuteri DSM 17648), which is a well-researched, clinically proven and patented unique probiotic strain highly effective and safe to manage patients infected with Helicobacter pylori.

Pylopass™ (Lactobacillus reuteri DSM 17648) helps reduce the bacterial load of H. pylori in the stomach in a highly targeted way. It works by forming coaggregates with H. pylori due to its molecular shape, a bit like Velcro. Molecules on the surface of Pylopass™ fit specifically with the structures on the surface of H. pylori. The coaggregation depends only on the mechanical binding of these structures. After coaggregation, it is excreted from the body through the digestive tract, thus reducing H. pylori levels (see figure 1, 2, 3 and 4). Pylopass™ can withstand the low pH of the stomach because it employs a mechanism that does not depend on survival in the gastric environment.

Pylopass™ (Lactobacillus reuteri DSM 17648) is considered as an ideal alternative or addition to eradication therapy or even as a preventive strategy to –

  • Reduce Helicobacter pylori (H. pylori) load and colonization 
  • Improves H. pylori eradication rate of standard therapy
  • Reduce GI symptoms & gastric inflammation



Each Helicoter Capsule contains Pylopass™ (Lactobacillus reuteri DSM 17648) 200 mg (20 Billion CFU) and Excipients.

Adults: Take 1 Capsule 1-2 times daily with meals, or as directed by your healthcare professional. Children over 6 years: Take 1 Capsule once daily with meals. 


The recommended duration of treatment is 4 weeks. The recommended duration of treatment is 4 weeks. To prevent the recurrence of H. pylori infection, the course of treatment could be repeated after 6 months of the completion of initial treatment. Before use, it is recommended to consult a doctor.


30 capsules. 15 capsules per 1 blister. 2 blisters per pack.



Perrery Farmaceutici S.r.l.

Corso San Lorenzo, 1, 37026 Pescantina, Verona (VR), Italy.